114 related articles for article (PubMed ID: 21442968)
1. [Neurofibromatosis type I--the pediatric endocrinologist's point of view].
Januś D; Wójcik M; Kalicka-Kasperczyk A; Roztoczyńska D; Wojtyś J; Tyrawa K; Dolezal-Ołtarzewska K; Wcisło B; Was M; Starzyk J
Przegl Lek; 2010; 67(11):1155-9. PubMed ID: 21442968
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of neurofibromatosis type 1].
Lozada Y; Alvarez-Valiente H; Argüelles M
Rev Neurol; 1998 Nov; 27(159):792-5. PubMed ID: 9859153
[TBL] [Abstract][Full Text] [Related]
3. [Von Recklinghausen neurofibromatosis in Lome, Togo].
Tchangaï-Walla K; Pitche P; Mijiyawa M; Grunitzky K
Med Trop (Mars); 1995; 55(2):185-6. PubMed ID: 7565007
[No Abstract] [Full Text] [Related]
4. Neurofibromatosis type 1: update on a common genetic condition.
Siqveland E; Pond D
Minn Med; 2009 Mar; 92(3):49-52. PubMed ID: 19400389
[TBL] [Abstract][Full Text] [Related]
5. [Neurofibromatosis type 1 complications in the pediatric age: follow-up of a hundred cases].
Bonnemaison E; Roze-Abert B; Lorette G; Sirinelli D; Boscq M; Mazjoub S; De Courtivron B; Bonnard C; Despert F; Toutain A; Maheut-Lourmière J; Barthez MA; Castelnau P;
Arch Pediatr; 2006 Jul; 13(7):1009-14. PubMed ID: 16716577
[TBL] [Abstract][Full Text] [Related]
6. The basics for the diagnosis and management of short stature: a pediatric endocrinologist's approach.
MacGillivray MH
Pediatr Ann; 2000 Sep; 29(9):570-5. PubMed ID: 11016050
[No Abstract] [Full Text] [Related]
7. [Neurofibromatosis type 1--own experiences].
Czajkowski G; Kałuzny J; Jatczak-Gaca A; Wysocki M
Klin Oczna; 2010; 112(1-3):45-8. PubMed ID: 20572503
[TBL] [Abstract][Full Text] [Related]
8. Effects of neurofibromatosis type 1 on children's development.
Haynes NM; Kirwan JR; McCrohan K
Soc Work Public Health; 2011; 26(4):444-53. PubMed ID: 21707352
[TBL] [Abstract][Full Text] [Related]
9. Eye disorders in neurofibromatosis (NF1).
Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
[TBL] [Abstract][Full Text] [Related]
10. Pediatric otorhinolaryngologic manifestations of endocrinological pathologies.
Luce FL; Sarandria D; Pozzobon G; Chiumello G; Bussi M
Int J Pediatr Otorhinolaryngol; 2009 Dec; 73 Suppl 1():S49-55. PubMed ID: 20114156
[TBL] [Abstract][Full Text] [Related]
11. [Structural CNS abnormalities responsible for coincidental occurrence of endocrine disorders, epilepsy and psychoneurologic disorders in children and adolescents].
Starzyk J; Kwiatkowski S; Kaciński M; Kroczka S; Wójcik M
Przegl Lek; 2010; 67(11):1120-6. PubMed ID: 21442961
[TBL] [Abstract][Full Text] [Related]
12. [Neurofibromatosis type 2 (NF2). Study of 7 patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Viaño J
Neurologia; 2009 Sep; 24(7):457-61. PubMed ID: 19921555
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1].
Blanchard G; Pinson S; Rousselle C; Lorthois S; Combemale P; Bernard M; Lion Francois L
Arch Pediatr; 2009 Dec; 16(12):1527-32. PubMed ID: 19864117
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
[TBL] [Abstract][Full Text] [Related]
15. Chiari I malformation and neurofibromatosis type 1.
Tubbs RS; Rutledge SL; Kosentka A; Bartolucci AA; Oakes WJ
Pediatr Neurol; 2004 Apr; 30(4):278-80. PubMed ID: 15087107
[TBL] [Abstract][Full Text] [Related]
16. Age at diagnosis of neurofibromatosis 1: an audit of practice.
Abecassis S; Bastuji-Garin S; Khosrotehrani K; Zeller J; Revuz J; Wolkenstein P
Dermatology; 2008; 216(4):347-8. PubMed ID: 18277076
[No Abstract] [Full Text] [Related]
17. Clinical features and surgical management of orbitotemporal neurofibromatosis: a retrospective interventional case series.
Altan-Yaycioglu R; Hintschich C
Orbit; 2010 Oct; 29(5):232-8. PubMed ID: 20812827
[TBL] [Abstract][Full Text] [Related]
18. [Neurofibromatosis 1: recommendations for management].
Pinson S; Créange A; Barbarot S; Stalder JF; Chaix Y; Rodriguez D; Sanson M; Bernheim A; D'incan M; Doz F; Stoll C; Combemale P; Kalifa C; Zeller J; Teillac-Hamel D; Lyonnet S; Zerah M; Lacour JP; Guillot B; Wolkenstein P
Ann Dermatol Venereol; 2001 Apr; 128(4):567-75. PubMed ID: 11395662
[No Abstract] [Full Text] [Related]
19. [Type 1 neurofibromatosis in Tunisia: 66 cases].
Gouider R; Azaiz MI; Kchouk M; Lasram L; Ben Osman A; Mrabet A
Ann Dermatol Venereol; 1994; 121(2):185-9. PubMed ID: 7979037
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
Thiagalingam S; Flaherty M; Billson F; North K
Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
